News

Sleep Better Columbus is now offering FDA-cleared oral appliance therapy for patients diagnosed with mild to moderate ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Ochsner Baton Rouge is now offering the FDA-approved Inspire device, a small implant that can be implanted in the body to ...
People diagnosed with obstructive sleep apnea may face more than just poor sleep and tired mornings. A new study finds they ...
A recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep ...
Sleep Apnea is characterized by several key symptoms that can significantly impact on your quality of life. The most ...
Microsleep refers to brief, involuntary episodes of sleep lasting just a few seconds during a person's waking hours.
Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.